{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:04:46Z","timestamp":1766153086469,"version":"3.48.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013420","name":"Tsumura and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colectomy for colon cancer typically results in gastrointestinal hypomotility. Daikenchuto, a herbal medicine traditionally used in Japan, is administered to alleviate gastrointestinal hypomotility. However, it is suspected to cause hepatobiliary injury. Therefore, in this comparative, retrospective cohort study, we aimed to assess the risk of daikenchuto administration-induced hepatobiliary injury post-colectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with colon cancer who underwent colectomy, excluding the population with a high risk of postoperative hepatobiliary injury, were included in this study (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200917,996). Specifically, patients who received daikenchuto within 4 days after colectomy or from the day of surgery to the first meal postoperatively and those who did not receive daikenchuto were assigned to the daikenchuto exposure and non-exposure groups, respectively. The primary outcome was the postoperative administration of cholagogues or hepatoprotective drugs. Multivariate logistic regression analysis was performed considering the perioperative risk factors for hepatobiliary injury. The analysis estimated the adjusted odds ratios to assess the risk of daikenchuto-induced hepatobiliary injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The frequencies of the postoperative administration of cholagogues or hepatoprotective drugs were 52 of 2,324 patients (2.24%) and 421 of 15,672 (2.69%) in the daikenchuto exposure and non-exposure groups, respectively. Furthermore, the adjusted odds ratio and 95% confidence interval (0.62\u20131.12) were &lt;\u20091 and included 1, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No association between daikenchuto and the risk of hepatobiliary injury was identified. Thus, our results imply that daikenchuto can be safely administered post-colectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      This study was registered in the Japan Registry of Clinical Trials (Trial ID: jRCT1031240102;\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/jrct.mhlw.go.jp\/en-latest-detail\/jRCT1031240102\" ext-link-type=\"uri\">https:\/\/jrct.mhlw.go.jp\/en-latest-detail\/jRCT1031240102<\/jats:ext-link>\n                      ) on May 22, 2024.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-025-05186-1","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:32:18Z","timestamp":1766147538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk assessment of daikenchuto-induced hepatobiliary injury in colon cancer patients post-colectomy: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Satoru","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"5186_CR1","unstructured":"World Health Organization. Colorectal cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer (2023). Accessed 8 Apr 2025."},{"key":"5186_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14:1732.","journal-title":"Cancers (Basel)"},{"key":"5186_CR3","unstructured":"World Health Organization. Cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer (2025). Accessed 8 Apr 2025."},{"key":"5186_CR4","unstructured":"Cancer Information Service, Center NC. Japan. Cancer Statistics (National Cancer Registry, Ministry of Health, Labor and Welfare). https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html#a14 (2025). Accessed 8 Apr 2025."},{"key":"5186_CR5","unstructured":"National Cancer Institute. Colon Cancer Treatment (PDQ\u00ae)\u2013Patient Version. https:\/\/www.cancer.gov\/types\/colorectal\/patient\/colon-treatment-pdq (2025). Accessed 8 Apr 2025."},{"key":"5186_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S1470-2045(18)30679-X","volume":"20","author":"E Angenete","year":"2019","unstructured":"Angenete E. The importance of surgery in colorectal cancer treatment. Lancet Oncol. 2019;20:6\u20137.","journal-title":"Lancet Oncol"},{"key":"5186_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1470-2045(18)30646-6","volume":"20","author":"S Benitez Majano","year":"2019","unstructured":"Benitez Majano S, Di Girolamo C, Rachet B, Maringe C, Guren MG, Glimelius B, et al. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study. Lancet Oncol. 2019;20:74\u201387.","journal-title":"Lancet Oncol"},{"key":"5186_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2188\/jea.JE20220347","volume":"34","author":"M Ota","year":"2024","unstructured":"Ota M, Taniguchi K, Asakuma M, Lee SW, Ito Y. Trends in the stage distribution of colorectal cancer during the COVID-19 pandemic in Japan: a nationwide hospital-claims data analysis. J Epidemiol. 2024;34:356\u201361.","journal-title":"J Epidemiol"},{"key":"5186_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jviscsurg.2016.08.010","volume":"153","author":"A Venara","year":"2016","unstructured":"Venara A, Neunlist M, Slim K, Barbieux J, Colas PA, Hamy A, et al. Postoperative ileus: pathophysiology, incidence, and prevention. J Visc Surg. 2016;153:439\u201346.","journal-title":"J Visc Surg"},{"key":"5186_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-021-01093-7","volume":"21","author":"Y Namba","year":"2021","unstructured":"Namba Y, Hirata Y, Mukai S, Okimoto S, Fujisaki S, Takahashi M, et al. Clinical indicators for the incidence of postoperative ileus after elective surgery for colorectal cancer. BMC Surg. 2021;21:80.","journal-title":"BMC Surg"},{"key":"5186_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1055\/s-0038-1677003","volume":"32","author":"CR Harnsberger","year":"2019","unstructured":"Harnsberger CR, Maykel JA, Alavi K. Postoperative ileus. Clin Colon Rectal Surg. 2019;32:166\u201370.","journal-title":"Clin Colon Rectal Surg"},{"key":"5186_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad054","volume":"7","author":"L Traeger","year":"2023","unstructured":"Traeger L, Koullouros M, Bedrikovetski S, Kroon HM, Moore JW, Sammour T. Global cost of postoperative ileus following abdominal surgery: meta-analysis. BJS Open. 2023;7:zrad054.","journal-title":"BJS Open"},{"key":"5186_CR13","unstructured":"The Japan Geriatrics Society. Guidelines for medical treatment and its safety in the elderly 2015 [in Japanese]. https:\/\/www.jpn-geriat-soc.or.jp\/publications\/other\/pharmacotherapy_guideline_2015.html (2016). Accessed 21 Nov 2024."},{"key":"5186_CR14","unstructured":"Japanese Pharmacopoeia 18th Edition, Crude Drugs and Related Drugs [June 7, 2021, the MHLW Ministerial Notification No. 220] 2021. 2021. https:\/\/www.mhlw.go.jp\/content\/11120000\/000904450.pdf. Accessed 30 Oct 2024."},{"key":"5186_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jamcollsurg.2015.03.004","volume":"221","author":"K Yoshikawa","year":"2015","unstructured":"Yoshikawa K, Shimada M, Wakabayashi G, Ishida K, Kaiho T, Kitagawa Y, et al. Effect of Daikenchuto, a traditional Japanese herbal medicine, after total gastrectomy for gastric cancer: a multicenter, randomized, double-blind, placebo-controlled, phase II trial. J Am Coll Surg. 2015;221:571\u20138.","journal-title":"J Am Coll Surg"},{"key":"5186_CR16","first-page":"5967","volume":"37","author":"M Ishizuka","year":"2017","unstructured":"Ishizuka M, Shibuya N, Nagata H, Takagi K, Iwasaki Y, Hachiya H, et al. Perioperative administration of traditional Japanese herbal medicine Daikenchuto relieves postoperative ileus in patients undergoing surgery for Gastrointestinal cancer: a systematic review and meta-analysis. Anticancer Res. 2017;37:5967\u201374.","journal-title":"Anticancer Res"},{"key":"5186_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11605-014-2730-y","volume":"19","author":"Y Akamaru","year":"2015","unstructured":"Akamaru Y, Takahashi T, Nishida T, Omori T, Nishikawa K, Mikata S, et al. Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial. J Gastrointest Surg. 2015;19:467\u201372.","journal-title":"J Gastrointest Surg"},{"key":"5186_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/hepr.13288","volume":"49","author":"M Aiso","year":"2019","unstructured":"Aiso M, Takikawa H, Tsuji K, Kagawa T, Watanabe M, Tanaka A, et al. Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan. Hepatol Res. 2019;49:105\u201310.","journal-title":"Hepatol Res"},{"key":"5186_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050678","volume":"16","author":"K Kimura","year":"2023","unstructured":"Kimura K, Kikegawa M, Kan Y, Uesawa Y. Identifying crude drugs in Kampo medicines associated with drug-induced liver injury using the Japanese adverse drug event report database: a comprehensive survey. Pharmaceuticals. 2023;16:678.","journal-title":"Pharmaceuticals"},{"key":"5186_CR20","first-page":"1973","volume":"32","author":"Y Katori","year":"2012","unstructured":"Katori Y, Tsukamoto M, Agenosono H. Investigation of the frequency of adverse drug reaction to Tsumura Daikenchuto extract granules for ethical use in Japan. Prog Med. 2012;32:1973\u201382.","journal-title":"Prog Med"},{"issue":"1","key":"5186_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2188\/jea.JE20200288","volume":"31","author":"K Hayashida","year":"2021","unstructured":"Hayashida K, Murakami G, Matsuda S, Fushimi K. History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan. J Epidemiol. 2021;31(1):1\u201311.","journal-title":"J Epidemiol"},{"key":"5186_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-66","volume":"13","author":"J Montomoli","year":"2013","unstructured":"Montomoli J, Erichsen R, Christiansen CF, Ulrichsen SP, Pedersen L, Nilsson T, et al. Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study. BMC Gastroenterol. 2013;13:66.","journal-title":"BMC Gastroenterol"},{"key":"5186_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/00365521.2017.1291719","volume":"52","author":"ES Bj\u00f6rnsson","year":"2017","unstructured":"Bj\u00f6rnsson ES. Drug-induced liver injury due to antibiotics. Scand J Gastroenterol. 2017;52:617\u201323.","journal-title":"Scand J Gastroenterol"},{"key":"5186_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092203","volume":"13","author":"E Giustiniano","year":"2021","unstructured":"Giustiniano E, Nisi F, Rocchi L, Zito PC, Ruggieri N, Cimino MM, et al. Perioperative management of complex hepatectomy for colorectal liver metastases: the alliance between the surgeon and the anesthetist. Cancers (Basel). 2021;13:2203.","journal-title":"Cancers (Basel)"},{"key":"5186_CR25","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","volume":"51","author":"D Candotti","year":"2009","unstructured":"Candotti D, Allain J-P. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798\u2013809.","journal-title":"J Hepatol"},{"key":"5186_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","volume":"33","author":"J Floyd","year":"2006","unstructured":"Floyd J, Mirza I, Sachs B, Perry MC. Hepatotoxicity of chemotherapy. Semin Oncol. 2006;33:50\u201367.","journal-title":"Semin Oncol"},{"key":"5186_CR27","unstructured":"Ministry of Health, Labour and, Welfare J. 9th NDB open data. 2024. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177221_00014.html (2024). Accessed 21 Nov 2024."},{"key":"5186_CR28","unstructured":"Council for International Organizations of Medical Sciences. A consensus by a CIOMS Working Group, Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting. 2020. https:\/\/cioms.ch\/wp-content\/uploads\/2020\/06\/CIOMS_DILI_Web_16Jun2020.pdf. Accessed 2 Apr 2024."},{"key":"5186_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"G Aithal","year":"2011","unstructured":"Aithal G, Watkins P, Andrade R, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806\u201315.","journal-title":"Clin Pharmacol Ther"},{"key":"5186_CR30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/pds.5099","volume":"29","author":"EH Tan","year":"2020","unstructured":"Tan EH, Ling ZJ, Ang PS, Sung C, Dan YY, Tai BC. Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance. Pharmacoepidemiol Drug Saf. 2020;29:1480\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"5186_CR31","unstructured":"Japan Society of Laboratory Medicine. Shared reference intervals for major laboratory tests in Japan [in Japanese]. Revised on January 25. 2019. https:\/\/www.jccls.org\/wp-content\/uploads\/2020\/11\/public_20190222.pdf (2019). Accessed 19 Sep 2025."},{"key":"5186_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","volume":"7","author":"A Xanthopoulos","year":"2019","unstructured":"Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019;7:87\u201397.","journal-title":"JACC Heart Fail"},{"key":"5186_CR33","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4254\/wjh.v7.i4.662","volume":"7","author":"I Mozos","year":"2015","unstructured":"Mozos I. Arrhythmia risk in liver cirrhosis. World J Hepatol. 2015;7:662\u201372.","journal-title":"World J Hepatol"},{"key":"5186_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030269","volume":"12","author":"D Miyamori","year":"2023","unstructured":"Miyamori D, Tanaka M, Sato T, Endo K, Mori K, Mikami T, et al. Coexistence of metabolic dysfunction-associated fatty liver disease and chronic kidney disease is a more potent risk factor for ischemic heart disease. J Am Heart Assoc. 2023;12:e030269.","journal-title":"J Am Heart Assoc"},{"key":"5186_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jdi.13756","volume":"13","author":"CH Lee","year":"2022","unstructured":"Lee CH, Lui DT, Lam KS. Non-alcoholic fatty liver disease and type 2 diabetes: an update. J Diabetes Investig. 2022;13:930\u201340.","journal-title":"J Diabetes Investig"},{"key":"5186_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","volume":"18","author":"A Pirillo","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18:689\u2013700.","journal-title":"Nat Rev Cardiol"},{"key":"5186_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.14218\/JCTH.2021.00271","volume":"10","author":"LD Averbukh","year":"2022","unstructured":"Averbukh LD, Turshudzhyan A, Wu DC, Wu GY. Statin-induced liver injury patterns: a clinical review. J Clin Transl Hepatol. 2022;10:543\u201352.","journal-title":"J Clin Transl Hepatol"},{"key":"5186_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5253623","volume":"2018","author":"P Sriuttha","year":"2018","unstructured":"Sriuttha P, Sirichanchuen B, Permsuwan U. Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials. Int J Hepatol. 2018;2018:5253623.","journal-title":"Int J Hepatol"},{"key":"5186_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jama.296.1.87","volume":"296","author":"PB Watkins","year":"2006","unstructured":"Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006;296:87\u201393.","journal-title":"JAMA"},{"key":"5186_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1574886311308030011","volume":"8","author":"SH Park","year":"2013","unstructured":"Park SH, Ishino R. Liver injury associated with antidepressants. Curr Drug Saf. 2013;8:207\u201323.","journal-title":"Curr Drug Saf"},{"key":"5186_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070201","volume":"380","author":"L Muratori","year":"2023","unstructured":"Muratori L, Lohse AW, Lenzi M. Diagnosis and management of autoimmune hepatitis. BMJ. 2023;380:e070201.","journal-title":"BMJ"},{"key":"5186_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","volume":"77","author":"D Marti-Aguado","year":"2022","unstructured":"Marti-Aguado D, Clemente-Sanchez A, Bataller R. Cigarette smoking and liver diseases. J Hepatol. 2022;77:191\u2013205.","journal-title":"J Hepatol"},{"key":"5186_CR43","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"S M\u00f8ller","year":"2013","unstructured":"M\u00f8ller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804\u201311.","journal-title":"Eur Heart J"},{"key":"5186_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/09638288809164103","volume":"10","author":"C Collin","year":"1988","unstructured":"Collin C, Wade DT, Davies S, Horne V. The Barthel ADL index: a reliability study. Int Disabil Stud. 1988;10:61\u20133.","journal-title":"Int Disabil Stud"},{"key":"5186_CR45","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","volume":"18","author":"JC Stoltzfus","year":"2011","unstructured":"Stoltzfus JC. Logistic regression: a brief primer. Acad Emerg Med. 2011;18:1099\u2013104.","journal-title":"Acad Emerg Med"},{"key":"5186_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","volume":"20","author":"DR Cox","year":"1958","unstructured":"Cox DR. The regression analysis of binary sequences. J R Stat Soc Ser B Stat Methodol. 1958;20:215\u201342.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"5186_CR47","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2023. http:\/\/www.R-project.org\/. Accessed 21 Nov 2024."},{"key":"5186_CR48","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Can Med Assoc J. 2005;172:367\u201379.","journal-title":"Can Med Assoc J"},{"key":"5186_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.806249","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, Luo Q, Tao Y, Sun X, Liu C. Pharmacotherapies for drug-induced liver injury: a current literature review. Front Pharmacol. 2022;12:806249.","journal-title":"Front Pharmacol"},{"key":"5186_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cld.2016.08.007","volume":"21","author":"H Saithanyamurthi","year":"2017","unstructured":"Saithanyamurthi H, Faust AJ. Drug-induced liver disease: clinical course. Clin Liver Dis. 2017;21:21\u201334.","journal-title":"Clin Liver Dis"},{"key":"5186_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.iliver.2023.06.001","volume":"2","author":"F-J Song","year":"2023","unstructured":"Song F-J, Liu H-L, Sun Y, Xu T-J, Li D-Z, Wang H-B, et al. Prednisolone therapy accelerates recovery of severe drug-induced liver injury: a prospective, randomized controlled study. iLIVER. 2023;2:156\u201362.","journal-title":"iLIVER"},{"key":"5186_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/1751-2980.12697","volume":"20","author":"PF Hu","year":"2019","unstructured":"Hu PF, Xie WF. Corticosteroid therapy in drug-induced liver injury: pros and cons. J Dig Dis. 2019;20:122\u20136.","journal-title":"J Dig Dis"},{"key":"5186_CR53","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222\u201361.","journal-title":"J Hepatol"},{"key":"5186_CR54","first-page":"16","volume-title":"Cohen J. Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. 1.5.5 proving the null hypothesis. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Routledge; 1988. pp. 16\u20137.","edition":"2"},{"key":"5186_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2036.2004.02092.x","volume":"20","author":"JH Rubenstein","year":"2004","unstructured":"Rubenstein JH, Laine L. Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2004;20:373\u201380.","journal-title":"Aliment Pharmacol Ther"},{"key":"5186_CR56","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/DCR.0000000000000114","volume":"57","author":"MB Bailey","year":"2014","unstructured":"Bailey MB, Davenport DL, Vargas HD, Evers BM, McKenzie SP. Longer operative time: deterioration of clinical outcomes of laparoscopic colectomy versus open colectomy. Dis Colon Rectum. 2014;57:616\u201322.","journal-title":"Dis Colon Rectum"},{"key":"5186_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.livres.2019.11.006","volume":"3","author":"W-X Ding","year":"2019","unstructured":"Ding W-X, Yang L. Alcohol and drug-induced liver injury: metabolism, mechanisms, pathogenesis and potential therapies. Liver Res. 2019;3:129\u201331.","journal-title":"Liver Res"},{"key":"5186_CR58","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s10620-020-06586-8","volume":"66","author":"H Nozawa","year":"2021","unstructured":"Nozawa H, Emoto S, Sonoda H, Kawai K, Sasaki K, Kaneko M, et al. Liver injury among Japanese patients treated using prophylactic enoxaparin after colorectal surgery. Dig Dis Sci. 2021;66:2805\u201315.","journal-title":"Dig Dis Sci"},{"key":"5186_CR59","unstructured":"ClinicalTrials.gov. Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection. https:\/\/clinicaltrials.gov\/study\/NCT04742907?a=14 (2025). Accessed 22 Sep 2025."}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05186-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:02:14Z","timestamp":1766152934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-025-05186-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5186"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05186-1","relation":{},"ISSN":["2662-7671"],"issn-type":[{"type":"electronic","value":"2662-7671"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Review Committee of Shiba Palace Clinic approved this study protocol (approval number: 155565_rn-37716). Informed consent was not required because the commercial data provided by Medical Data Vision Inc. had already been anonymously processed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SW, YW, and TA are employed by Tsumura & Co., receive salaries, and hold shares in the company. TA is a part-time lecturer at the University of Occupational and Environmental Health, Japan, assisting in social implementation of the university\u2019s patents and receives a salary. JN, KH, and YF received a consulting fee from Tsumura & Co. for this study. YF has acted as a medical adviser at Tsumura & Co. and received an inclusive advisory fee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}